drugset / Trial / NCT00215410

Study in Patients With Asthma

NCT00215410

Phase 2 Completed 36 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

Timeline

Start
Primary completion
2003-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified

Indications